Cargando…

Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation

In Alzheimer’s disease (AD), the reduction in acetylcholinesterase (AChE) enzymatic activity is not paralleled with changes in its protein levels, suggesting the presence of a considerable enzymatically inactive pool in the brain. In the present study, we validated previous findings, and, since inac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortés-Gómez, María-Ángeles, Barberá, Víctor M., Alom, Jordi, Sáez-Valero, Javier, García-Ayllón, María-Salud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864477/ https://www.ncbi.nlm.nih.gov/pubmed/36674948 http://dx.doi.org/10.3390/ijms24021437

Ejemplares similares

Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression
por: Cortés‐Gómez, María‐Ángeles, et al.
Publicado: (2020)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

CSF Presenilin-1 complexes are increased in Alzheimer’s disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2013)

Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2017)

Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis
por: García-Ayllón, María-Salud, et al.
Publicado: (2012)

Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
por: Campanari, Maria-Letizia, et al.
Publicado: (2016)

Revisiting the Role of Acetylcholinesterase in Alzheimer’s Disease: Cross-Talk with P-tau and β-Amyloid
por: García-Ayllón, María-Salud, et al.
Publicado: (2011)

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2016)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Intracellular trafficking of TREM2 is regulated by presenilin 1
por: Zhao, Yingjun, et al.
Publicado: (2017)

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy
por: Lennol, Matthew P., et al.
Publicado: (2022)

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)

A Presenilin-2–ARF4 trafficking axis modulates Notch signaling during epidermal differentiation
por: Ezratty, Ellen J., et al.
Publicado: (2016)

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021)

Parkin acts as a transcription factor modulating presenilin-1 and presenilin-2 promoter transactivations
por: Duplan, Eric, et al.
Publicado: (2013)

The presenilins
por: Tandon, Anurag, et al.
Publicado: (2002)

Plasma ACE2 species are differentially altered in COVID‐19 patients
por: García‐Ayllón, María‐Salud, et al.
Publicado: (2021)

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
por: Agüero, Pablo, et al.
Publicado: (2020)

Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane
por: Kaether, Christoph, et al.
Publicado: (2002)

Adult hippocampal neurogenesis occurs in the absence of Presenilin 1 and Presenilin 2
por: Dhaliwal, Jagroop, et al.
Publicado: (2018)

Structure and dynamics of γ-secretase with presenilin 2 compared to presenilin 1
por: Dehury, Budheswar, et al.
Publicado: (2019)

Specificity of presenilin‐1‐ and presenilin‐2‐dependent γ‐secretases towards substrate processing
por: Stanga, Serena, et al.
Publicado: (2017)

Brain cholinergic impairment in liver failure
por: García-Ayllón, María-Salud, et al.
Publicado: (2008)

Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation
por: Mah, Alex L., et al.
Publicado: (2000)

Presenilins regulate αβ T cell development by modulating TCR signaling
por: Laky, Karen, et al.
Publicado: (2007)

ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels
por: Agüero-Rabes, Pablo, et al.
Publicado: (2023)

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2017)

Ibuprofen Rescues Abnormalities in Periodontal Tissues in Conditional Presenilin 1 and Presenilin 2 Double Knockout Mice
por: Su, Jiansheng, et al.
Publicado: (2013)

Structural biology of presenilin 1 complexes
por: Li, Yi, et al.
Publicado: (2014)

Presenilin mutations and their impact on neuronal differentiation in Alzheimer’s disease
por: Hernández-Sapiéns, Mercedes A., et al.
Publicado: (2021)

Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome
por: Vázquez-Costa, Juan Francisco, et al.
Publicado: (2021)

Pathological and physiological functions of presenilins
por: Vetrivel, Kulandaivelu S, et al.
Publicado: (2006)

Presenilin/γ-Secretase and Inflammation
por: Saura, Carlos A.
Publicado: (2010)

Discovery of novel benzophenone integrated derivatives as anti-Alzheimer’s agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach
por: Martiz, Reshma Mary, et al.
Publicado: (2022)

Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells
por: Jumpertz, Thorsten, et al.
Publicado: (2012)

Presenilin 2 Is the Predominant γ-Secretase in Microglia and Modulates Cytokine Release
por: Jayadev, Suman, et al.
Publicado: (2010)

Inhibition of the Neuronal Calcium Sensor DREAM Modulates Presenilin-2 Endoproteolysis
por: Naranjo, Rocío, et al.
Publicado: (2018)

Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β production
por: Zoltowska, Katarzyna Marta, et al.
Publicado: (2017)

Modeling Presenilin-Dependent Familial Alzheimer's Disease: Emphasis on Presenilin Substrate-Mediated Signaling and Synaptic Function
por: Parent, Angèle T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7j5m0jt3ju6jtul0q3gl780ser